RNAi Ribonucleic Acid interence

The future of RNAi in the age of gene editing

Read more

Has à la carte genetic medicine arrived?

Read more

Silence Therapeutics Plc: Consolidating the RNAi therapeutics space

Read more

Delivery systems may be crucial to RNAi therapies

Read more

RXi Pharmaceuticals goes public

Read more

Silence Therapeutics:Silencing the gene that codes the protein

Read more